These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23639991)

  • 1. Glycemic memories and the epigenetic component of diabetic nephropathy.
    Keating ST; El-Osta A
    Curr Diab Rep; 2013 Aug; 13(4):574-81. PubMed ID: 23639991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.
    Tonna S; El-Osta A; Cooper ME; Tikellis C
    Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Mechanisms in Diabetic Kidney Disease.
    Thomas MC
    Curr Diab Rep; 2016 Mar; 16(3):31. PubMed ID: 26908156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic memory and diabetic nephropathy: Beneficial effects of natural epigenetic modifiers.
    Kushwaha K; Sharma S; Gupta J
    Biochimie; 2020 Mar; 170():140-151. PubMed ID: 31954720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modifications in the pathogenesis of diabetic nephropathy.
    Reddy MA; Tak Park J; Natarajan R
    Semin Nephrol; 2013 Jul; 33(4):341-53. PubMed ID: 24011576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations.
    Xu L; Natarajan R; Chen Z
    Curr Diab Rep; 2019 Feb; 19(3):9. PubMed ID: 30730019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.
    Thomas MC
    Adv Chronic Kidney Dis; 2014 May; 21(3):311-7. PubMed ID: 24780460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice.
    Reddy MA; Sumanth P; Lanting L; Yuan H; Wang M; Mar D; Alpers CE; Bomsztyk K; Natarajan R
    Kidney Int; 2014 Feb; 85(2):362-73. PubMed ID: 24088954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting epigenetic regulators for treating diabetic nephropathy.
    Kushwaha K; Garg SS; Gupta J
    Biochimie; 2022 Nov; 202():146-158. PubMed ID: 35985560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of epigenetics in the pathology of diabetic complications.
    Villeneuve LM; Natarajan R
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F14-25. PubMed ID: 20462972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms.
    Villeneuve LM; Natarajan R
    Contrib Nephrol; 2011; 170():57-65. PubMed ID: 21659758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
    Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
    Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors.
    Kiss E; Kränzlin B; Wagenblaβ K; Bonrouhi M; Thiery J; Gröne E; Nordström V; Teupser D; Gretz N; Malle E; Gröne HJ
    Am J Pathol; 2013 Mar; 182(3):727-41. PubMed ID: 23318573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
    Okabe J; Orlowski C; Balcerczyk A; Tikellis C; Thomas MC; Cooper ME; El-Osta A
    Circ Res; 2012 Apr; 110(8):1067-76. PubMed ID: 22403242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.
    Togliatto G; Dentelli P; Brizzi MF
    J Diabetes Res; 2015; 2015():373708. PubMed ID: 26064979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemic memory in metabolism and cancer.
    Lee C; An D; Park J
    Horm Mol Biol Clin Investig; 2016 May; 26(2):77-85. PubMed ID: 27227713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic phenomena linked to diabetic complications.
    Pirola L; Balcerczyk A; Okabe J; El-Osta A
    Nat Rev Endocrinol; 2010 Dec; 6(12):665-75. PubMed ID: 21045787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: implication in metabolic memory.
    Takizawa F; Mizutani S; Ogawa Y; Sawada N
    Biochem Biophys Res Commun; 2013 Mar; 433(1):66-72. PubMed ID: 23454124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.